Utility of the BRAFT1799Amutation in papillary thyroid cancer / 中华内分泌代谢杂志

ABSTRACT

Significant progress has been made toward understanding the tumorigenic role and clinical significance of the T1799A B-type Raf kinase(BRAF)mutation in papillary thyroid cancer(PTC). With these advances, it has become clearer that BRAF mutation will likely have significant impact on the clinical management.